The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Valvular heart disease and/or dysfunction
Publications
Drug-induced valvular heart disease: an update.
Archives of cardiovascular diseases 2013 May;106;333-9 — 2013 May — 333-9
Boutet K, Frachon I, Jobic Y, Gut-Gobert C, Leroyer C, Carlhant-Kowalski D, Sitbon O, Simonneau G, Humbert M
Fenfluramine-like cardiovascular side-effects of benfluorex.
The European respiratory journal 2009 Mar;33;684-8 — 2009 Mar — 684-8
Valvular heart disease associated with dexfenfluramine.
The New England journal of medicine 1997 Aug 28;337;636 — 1997 Aug 28 — 636